The Biologics News and Reports Portal

Show Cart

Therapeutic Proteins & Peptides

Results 11 - 17 of 17

May 2013 Competitor Analysis: Coagulation Factors

600.00 €

Feb 2013 Competitor Analysis: FSH, hCG and LH - Therapeutic Proteins for Assisted Reproductive Technology (ART)

250.00 €

Jan 2013 Competitor Analysis: Enzyme Replacement Therapies

300.00 €

Mar 2012 Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists - A Target Pipeline and Stakeholder Analysis 2012

1,950.00 €

Oct 2011 Coagulation Factors 2011 – who does meet the market needs? A Pipeline Assessment, Market Survey and Corporate Benchmark Analysis

1,920.00 €

2,400.00 €

(Discount: 20.00%)

Sep 2010 Coagulation Factors 2010 - The Portfolio Aspect as Decisive Force: A Competitive Landscape and R&D Pipeline Analysis of Hemostasis Proteins

2,495.00 €

Aug 2009 Coagulation Factors 2009: Target Pipeline and Corporate Benchmark Analysis

2,450.00 €

Start
Prev
1
2
Next
End

Shopping cart

Cart empty

Shopping cart

Cart empty

Latest report

Targeted Protein Degradation by Novel PROTACs and Molecular Glues 2020: a landscape analysis of companies, technologies, targets, investors and partners from an industry perspective

Featured Products

Report Package: “Drug the Undruggable” Technologies

RNA-Targeted Small Molecules 2019: a landscape analysis of companies, technologies, targets, investors and partners from an industry perspective

T-Cell & NK-Cell Engaging Bispecific Antibodies 2019: a business, stakeholder, technology and pipeline analysis

Therapeutic Proteins & Peptides

May 2013 Competitor Analysis: Coagulation Factors

Feb 2013 Competitor Analysis: FSH, hCG and LH - Therapeutic Proteins for Assisted Reproductive Technology (ART)

Jan 2013 Competitor Analysis: Enzyme Replacement Therapies

Mar 2012 Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists - A Target Pipeline and Stakeholder Analysis 2012

Oct 2011 Coagulation Factors 2011 – who does meet the market needs? A Pipeline Assessment, Market Survey and Corporate Benchmark Analysis

Sep 2010 Coagulation Factors 2010 - The Portfolio Aspect as Decisive Force: A Competitive Landscape and R&D Pipeline Analysis of Hemostasis Proteins

Aug 2009 Coagulation Factors 2009: Target Pipeline and Corporate Benchmark Analysis

Shopping cart

Latest report

Featured Products

Latest Target Pipeline

Shopping cart

Latest report

Featured Products

Latest Target Pipeline

La Merie Biologics

FREE Weekly News Bulletin

2020 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing